From vanA Enterococcus hirae to vanA Enterococcus faecium : a Study of Feed Supplementation with Avoparcin and Tylosin in Young Chickens
Authors:
- 1 May 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (5) , 1137-1143
Abstract
Fifteen newborn chickens were isolated in separate cages after 1 month of living together, divided into three groups, and challenged for 5 weeks with seed food which either was supplemented with avoparcin (10 mg/kg of animal food) or tylosin (40 mg/kg) or was nonsupplemented. At 9 weeks of age and after the 5-week challenge, all chickens received nonsupplemented feed for 4 additional weeks. At 4, 9, and 13 weeks of life, feces were collected and inoculated on M- Enterococcus agar plates with and without vancomycin (4 μg/ml). vanA -containing Enterococcus hirae was isolated from 11 of 15 chickens before antibiotic challenge, without detection of vancomycin-resistant Enterococcus faecium . At 9 weeks of age and after the 5-week avoparcin challenge, vanA E. hirae strains were no longer detected, but five of five chickens now had vanA E. faecium . At a lower frequency, vanA E. faecium had also displaced vanA E. hirae in both the tylosin group (one of four chickens) and the control group (two of five chickens). One month after avoparcin discontinuation, the number of chickens colonized with vanA E. faecium decreased from five to one. All vanA -containing E. hirae strains detected in the first month of life and most of the vanA -containing E. faecium strains detected in the second month of life showed identical Apa I and Sma I restriction patterns, respectively, when analyzed by pulsed-field gel electrophoresis. All vanA E. hirae isolates transferred glycopeptide and macrolide resistance to Enterococcus faecalis JH2-2 in vitro; the level of glycopeptide resistance was higher in the transconjugants than in the donor E. hirae strains. These data suggest that E. hirae may be a significant source of vanA determinants with the potential of transfer to other enterococcal species from humans or animals.Keywords
This publication has 48 references indexed in Scilit:
- In vivo testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for species identificationFEMS Immunology & Medical Microbiology, 1998
- In vivo testing of anEnterococcus faecalis efaAmutant and use ofefaAhomologs for species identificationFEMS Immunology & Medical Microbiology, 1998
- Influence of Oral Glycopeptides on the Fecal Flora of Human Volunteers: Selection of Highly Glycopeptide-Resistant EnterococciThe Journal of Infectious Diseases, 1996
- Glycopeptide-Resistant Enterococcus faecium Outside Hospitals: A CommentaryMicrobial Drug Resistance, 1995
- Editorial Response: What Can We Do About Vancomycin-Resistant Enterococci?Clinical Infectious Diseases, 1995
- A survey of antimicrobial susceptibility of clinical isolates of Enterococcus spp. from Irish hospitalsJournal of Antimicrobial Chemotherapy, 1995
- van A-Mediated vancomycin-resistant Enterococcus spp. in sewageJournal of Antimicrobial Chemotherapy, 1994
- Environmental strains ofEnterococcus faeciumwith inducible high-level resistance to glycopeptidesFEMS Microbiology Letters, 1993
- Composition of the enterococcal and streptococcal intestinal flora of poultryJournal of Applied Microbiology, 1991
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988